U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2018
436
Name Type Language
GALCANEZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
GALCANEZUMAB [MI]
Common Name English
Galcanezumab [WHO-DD]
Common Name English
LY2951742
Code English
LY-2951742
Code English
galcanezumab [INN]
Common Name English
GALCANEZUMAB [JAN]
Common Name English
GALCANEZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE) (HUMAN-MUS MUSCULUS CLONE III HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS CLONE III .KAPPA.-CHAIN, DIMER
Common Name English
Classification Tree Code System Code
WHO-ATC N02CX08
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
Code System Code Type Description
SMS_ID
100000169982
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
WIKIPEDIA
Galcanezumab
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
USAN
CD-46
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
FDA UNII
55KHL3P693
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
ChEMBL
CHEMBL3707328
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
RXCUI
2058846
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
MERCK INDEX
m12105
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
EVMPD
SUB183792
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
LACTMED
Galcanezumab
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
DAILYMED
55KHL3P693
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
DRUG BANK
DB14042
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
NCI_THESAURUS
C166816
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
DRUG CENTRAL
5316
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
CAS
1578199-75-3
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
RXCUI
2058868
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
ALTERNATIVE
INN
10277
Created by admin on Sat Dec 16 11:04:47 GMT 2023 , Edited by admin on Sat Dec 16 11:04:47 GMT 2023
PRIMARY
ACTIVE MOIETY
GALCANEZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966